Johnson & Johnson: all 3,718 studies

Page 7 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-FiloCompletedNCT02598388Phase 2Results posted
• Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact LensesCompletedNCT02595502Not applicableResults posted
• A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency DepartmentCompletedNCT02584660Phase 4Results posted
• Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type PsoriasisCompletedNCT02581345Phase 3Results posted
• ATTUNE Single-Use Instrumentation vs. ATTUNE Reusable Instrumentation in Primary Total Knee ArthroplastyCompletedNCT02574312Not applicableResults posted
• A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and SimeprevirCompletedNCT02569710Phase 2Results posted
• An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's DementiaTerminatedNCT02569398Phase 2/3Results posted
• Evaluation of Three Daily Disposable Contact LensesCompletedNCT02568254Not applicableResults posted
• An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel DiseaseTerminatedNCT02566889Phase 4Results posted
• Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) AdultsCompletedNCT02564523Phase 2Results posted
• The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial HypertensionCompletedNCT02558231Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer ParticipantsCompletedNCT02555878Phase 3Results posted
• Clinical Study to Assess the Efficacy and Safety of Macitentan in Patients With Pulmonary Hypertension After Left Ventricular Assist Device ImplantationCompletedNCT02554903Phase 2Results posted
• A Clinical Trial to Evaluate Investigational Silicone Hydrogel Contact Lenses Worn Continuously for One WeekCompletedNCT02543528Not applicableResults posted
• Evaluation of 8.5 vs 9.0 Base Curve for 1-DAY ACUVUE(r) TruEye(r) Brand Contact LensesCompletedNCT02537522Phase 4Results posted
• Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction DeviceTerminatedNCT02532517Not applicableResults posted
• A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A InfectionCompletedNCT02532283Phase 2Results posted
• Evaluation of a Johnson & Johnson Vision Care Investigational Contact Lens Compared to a Marketed Monthly Replacement Contact LensCompletedNCT02515994Not applicableResults posted
• Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-FiloCompletedNCT02509494Phase 3Results posted
• The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux DiseaseCompletedNCT02505945Phase 4Results posted
• An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious DistressCompletedNCT02498392Phase 2Results posted
• A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionCompletedNCT02497287Phase 3Results posted
• A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionCompletedNCT02493868Phase 3Results posted
• A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPCActive, not recruitingNCT02489318Phase 3Results posted
• Analysis of Revascularization in Ischemic Stroke With EmboTrapCompletedNCT02488915Not applicableResults posted
• SMART China, A Multi-center Clinical Registry StudyCompletedNCT02485925Phase 4Results posted
• An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive DisorderCompletedNCT02473289Phase 2Results posted
• An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyCompletedNCT02472145Phase 2/3Results posted
• Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial HypertensionCompletedNCT02471183Phase 3Results posted
• A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of TreatmentCompletedNCT02469155Phase 3Results posted
• Posterior Spinal Fusion With Two Energy Dissection TechniquesTerminatedNCT02465099Phase 4Results posted
• A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTerminatedNCT02462473Phase 2Results posted
• Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHDTerminatedNCT02461134Phase 2Results posted
• The EVICEL® Neurosurgery Phase III StudyCompletedNCT02457546Phase 3Results posted
• Performance of a Multifocal Contact Lens - Presbyopia StudyCompletedNCT02450747Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02438787Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial SpondyloarthritisTerminatedNCT02437162Phase 3Results posted
• A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety DisorderCompletedNCT02432703Phase 2Results posted
• A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or SchizophreniformCompletedNCT02431702Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected SubjectsCompletedNCT02431247Phase 3Results posted
• LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve GastrectomyCompletedNCT02429830Not applicableResults posted
• A Comparison of Two Daily Disposable Soft Contact LensesCompletedNCT02427477Not applicableResults posted
• Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisCompletedNCT02425644Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionCompletedNCT02422186Phase 3Results posted
• A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 InfectionCompletedNCT02421211Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedNCT02418585Phase 3Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedNCT02417064Phase 3Results posted
• A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy AdultsCompletedNCT02416453Phase 2Results posted
• An Efficacy and Safety Proof of Concept Study of Daratumumab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular LymphomaTerminatedNCT02413489Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT02407236Phase 3Results posted
• An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial SpondyloarthritisTerminatedNCT02407223Phase 3Results posted
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease SpectrumTerminatedNCT02406027Phase 2Results posted
• Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy SkinTerminatedNCT02404493Not applicableResults posted
• Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional EmmetropesCompletedNCT02394925Not applicableResults posted
• 2-week Evaluation of Marketed Silicone Hydrogel Contact Lenses in Indian PopulationCompletedNCT02394808Not applicableResults posted
• Investigation of Ocular Signs & Symptoms in Wearers Fitted With Contact Lenses Following Digital Device UseCompletedNCT02394756Not applicableResults posted
• PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical TrialCompletedNCT02382016Phase 4Results posted
• Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)CompletedNCT02369848Not applicableResults posted
• An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial CancerActive, not recruitingNCT02365597Phase 2Results posted
• Clinical and Laboratory Study of Lysozyme Deposition on Daily Disposable Contact LensesCompletedNCT02365298Not applicableResults posted
• SMART-SF Radiofrequency Ablation Safety StudyCompletedNCT02359890Phase 3Results posted
• Tolerance Evaluation of a Nighttime Moisturizing Balm on Babies and Adults With EczemaCompletedNCT02357940Not applicableResults posted
• Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement TherapyCompletedNCT02355665Phase 3Results posted
• Assessment of Contact Lens Wettability Using Wavefront AberrometryCompletedNCT02349438Not applicableResults posted
• A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus ErythematosusCompletedNCT02349061Phase 2Results posted
• Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 InfectionCompletedNCT02349048Phase 2Results posted
• Effects of Multifocal Contact Lens on Ocular TissueCompletedNCT02345720Not applicableResults posted
• A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic MalignanciesCompletedNCT02329847Phase 1/2Results posted
• Central Corneal Swelling With Silicone Hydrogel MaterialsCompletedNCT02328937Not applicableResults posted
• An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type PsoriasisCompletedNCT02325219Phase 3Results posted
• Trial to Test if Antibiotic Ointments & Cream Will Sting After Application on a Minor Wound After Tape Stripping InjuryCompletedNCT02320695Not applicableResults posted
• Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)CompletedNCT02319759Phase 2Results posted
• A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaCompletedNCT02316106Phase 2Results posted
• Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) PreventionCompletedNCT02315703Phase 1/2Results posted
• Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and ReconstructionCompletedNCT02312856Not applicableResults posted
• REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtensionCompletedNCT02310672Phase 4Results posted
• Handling Comparison Between Two Contact Lens TypesCompletedNCT02310126Not applicableResults posted
• The Paediatric EVICEL® Neuro StudyTerminatedNCT02309645Phase 3Results posted
• A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary SyndromeCompletedNCT02293395Phase 2Results posted
• A Trial to Assess the Antipsychotic Efficacy of ITI-007CompletedNCT02282761Phase 3Results posted
• Harmonic ACE®+7 Shears in Laparoscopic HysterectomyCompletedNCT02278640Phase 4Results posted
• A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate TherapyCompletedNCT02277444Phase 3Results posted
• Early Feasibility Study of the Neovasc Tiara™ Mitral Valve SystemCompletedNCT02276547Not applicableResults posted
• Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected ParticipantsCompletedNCT02269917Phase 3Results posted
• A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected ParticipantsCompletedNCT02268864Phase 2Results posted
• An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver DiseaseCompletedNCT02262728Phase 2Results posted
• An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)Active, not recruitingNCT02257736Phase 3Results posted
• Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple MyelomaCompletedNCT02252172Phase 3Results posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus InfectionCompletedNCT02250807Phase 3Results posted
• Harmonic ACE®+7 Shears in Laparoscopic ColectomyCompletedNCT02248246Phase 4Results posted
• Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese ParticipantsCompletedNCT02243202Phase 2Results posted
• A Clinical Trial to Test the Effect of Marketed Mouth Rinses on Decreasing Plaque and Gum InflammationCompletedNCT02233998Not applicableResults posted
• The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding StudyCompletedNCT02227992Phase 3Results posted
• The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding StudyCompletedNCT02227706Phase 3Results posted
• Evaluation of an Investigational Multifocal LensCompletedNCT02223754Not applicableResults posted
• Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol TherapyCompletedNCT02217566Phase 2Results posted
• Comparison of Two Marketed Lenses in a Controlled EnvironmentCompletedNCT02212301Not applicableResults posted
• A Dental Pain Study to Test the Effectiveness of a New Pain Reliever MedicineCompletedNCT02209181Phase 2Results posted
• A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and RetreatmentCompletedNCT02207244Phase 3Results posted
• A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type PsoriasisCompletedNCT02207231Phase 3Results posted

← Johnson & Johnson overview and focus areas